Provided By GlobeNewswire
Last update: Jul 9, 2025
Veteran clinical leader with successful track record and experience to help guide the Company’s clinical strategy in Fibrostenotic Crohn’s Disease and Ulcerative Colitis
Read more at globenewswire.com1
-0.02 (-1.96%)
Find more stocks in the Stock Screener